01/9/21 - With the 2021 Western Australian BioSymposium just around the corner, Life Sciences WA had a brief chat with one of the Industry Panellists - Jon Ince, Biopharma Sales Leader with Cytiva Australia and New Zealand.
Jon, tell us a little about Cytiva.
Cytiva is a global life sciences leader dedicated to advancing and accelerating therapeutics. Cytiva is a trusted partner to customers that undertake life-saving activities ranging from biological research to developing innovative vaccines, biologic drugs, and novel cell and gene therapies. Cytiva brings speed, efficiency and capacity to research and manufacturing workflows, enabling the development, manufacture and delivery of transformative medicines to patients.
You’ve been involved with the WA BioSymposium before, what do you think makes this event unique?
There tends to be an historical focus for Life Sciences on the East Coast of Australia; this forum is a magnet to bring collaboration, networking, and partnership opportunities to Perth and in the incredible ecosystem that exists here. The most valuable piece has been the various universities, institutes and organisations coming together as one – It is certainly a successful model of engagement that I have pointed others toward.
In your capacity with Cytiva, what types of new innovations, pharmaceuticals or technology are you actively interested in?
Cytiva’s role as a tools and technology provide in the Biopharmaceutical and Cell & Gene Therapy space is to work with our customers and partners to accelerate their time to clinical trials and commercial manufacturing. Our goal locally, is to foster an ecosystem for biopharma clinical development to retain more value in Australia for longer and encourage a greater amount commercial biopharma manufacturing here in Australia; this has been shown to be particularly important of the last 18 months.
For the BioSymposium presenters, what do you think makes a great presentation from your perspective, and are there any key points that our presenters should be looking to do?
Like any good story, a good presentation needs to articulate a clear problem statement. If seeking a commercial partner, a clear line of sight to future commercial revenue is critical, but often skipped over. Confidence in the of the problem and the market segment you are targeting is key.
Lastly, what do you think is the most important criteria for success in any medical device/pharmaceutical development?
Speed. Medical device/pharmaceutical development are some of the most highly competitive market segments globally. At Cytiva, we have seen those that select a partner that can help you fail fast, accelerate your clinical development and de-risk your venture as you scale, have been those that are and have been successful.
Register now to see the latest in life science innovations presented virtually, along with the interactive industry panel discussion.